Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genmab On The Hunt For Late-Stage Assets

Feb 15 2024

• By Kevin Grogan

Jan van de Winkel — Jan van de Winkel • Source: Genmab

Related Content

Genmab Geared Up To Launch Epkinly With AbbVie

May 22 2023

Europe Biotech Heavyweights Genmab And Argenx Ink Antibody Alliance

Apr 17 2023

Genmab/AbbVie Look To Encroach On Roche’s Turf With Epkinly Follicular Lymphoma Results

Jun 28 2023

Related Companies

Genmab A/S

Johnson & Johnson

argenx N.V.

Novartis AG

Horizon Therapeutics plc

Pfizer Inc.

Additional Topics

Sales & Earnings M & A Business Strategies Commercial Deals Cancer BioPharmaceutical

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.